Volume 19, Number 10—October 2013
Research
Genetic Recombination and Cryptosporidium hominis Virulent Subtype IbA10G2
Table 3
Population | No. samples | No. segregating sites analyzed | No. pairwise comparisons | No. significant pairwise comparisons† | Zns | |D'| | LD | Estimate of R/gene | Minimum no. recombination events |
---|---|---|---|---|---|---|---|---|---|
Including gp60‡ | |||||||||
All | 53 | 362 | 47,895 | 25,904 (8,714) | 0.2711 | Y = 0.9289 – 0.0299X | Incomplete | 5.0 | 33 |
IaA13R8(7) | 10 | 20 | 190 | 0 | 0.7581 | Y = 1.0000 + 0.0000X | Complete | 0.001 | 0 |
IbA10G2 | 26 | 31 | 465 | 160 (140) | 0.3660 | Y = 0.9342 + 0.0001X | Incomplete | 0.3 | 4 |
IdA10 | 6 | 14 | 91 | 0 | 1.0000 | Y = 1.0000 + 0.0000X | Complete | 0.001 | 0 |
IdA20 | 5 | 3 | 3 | 0 | 0.3750 | Y = 1.0000 + 0.0000X | Complete | 0.001 | 0 |
IeA11G3T3 | 6 | 19 | 171 | 0 | 1.0000 | Y = 1.0000 + 0.0000X | Complete | 0.001 | 0 |
Excluding gp60§ | |||||||||
All | 53 | 65 | 2080 | 921 (333) | 0.2184 | Y = 0.7886 + 0.0051X | Incomplete | 1.8 | 6 |
IaA13R8(7) | 10 | 20 | 190 | 0 | 0.7581 | Y = 1.0000 + 0.0000X | Complete | 0.001 | 0 |
IbA10G2 | 26 | 31 | 465 | 160 (140) | 0.3660 | Y = 0.9302 + 0.0010X | Incomplete | 0.3 | 4 |
IdA10 | 6 | 14 | 91 | 0 | 1.0000 | Y = 1.0000 + 0.0000X | Complete | 0.001 | 0 |
IdA20 | 5 | 3 | 3 | 0 | 0.3750 | Y = 1.0000 + 0.0000X | Complete | 0.001 | 0 |
IeA11G3T3 | 6 | 19 | 171 | 0 | 1.0000 | Y = 1.0000 + 0.0000X | Complete | 0.001 | 0 |
*Zns, interlocus genetic association; |D'|, linkage disequilibrium (LD) value, where Y is LD value and X is nucleotide distance in kilobases; gp 60, 60-kDa glycoprotein gene.
†By Fisher exact test (after Bonferroni correction).
‡Based on concatenated multilocus gene sequence of all loci (15,717 bp).
§Based on concatenated multilocus gene sequence of all loci excluding gp60 (14,768 bp).
Page created: September 16, 2013
Page updated: September 16, 2013
Page reviewed: September 16, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.